Metabolomics study of APETx2 post-conditioning on myocardial ischemia-reperfusion injury
2024

Study on APETx2's Effects on Heart Injury

Sample size: 24 publication 10 minutes Evidence: moderate

Author Information

Author(s): Li Jing, Wei Yiyong, Wang Yi, Zhang Yue, Xu Ying, Ma Huanhuan, Ma Lulin, Zeng Qingfan

Primary Institution: Zunyi Medical University

Hypothesis

APETx2 post-conditioning can improve cardiac function and affect principal metabolic pathways in hearts with myocardial ischemia-reperfusion injury.

Conclusion

APETx2 post-conditioning may alleviate myocardial ischemia-reperfusion injury through specific metabolic alterations.

Supporting Evidence

  • APETx2 post-conditioning stabilized hemodynamics in the isolated rat heart model of MIRI.
  • APETx2 reduced myocardial infarct size and mitigated mitochondrial damage.
  • Specific metabolites involved in autophagy and endocannabinoid signaling pathways were restored by APETx2 post-conditioning.

Takeaway

This study found that a special treatment called APETx2 can help protect the heart from damage when blood flow is restored after being blocked.

Methodology

Rat hearts were subjected to Langendorff perfusion and treated with the ASIC3-specific inhibitor APETx2 to observe molecular and morphological changes.

Limitations

The study did not include in vivo experiments to confirm the metabolic changes and protective effects of APETx2 post-conditioning.

Participant Demographics

Sprague-Dawley rats, 250–300 g, 16–20 weeks old, not limited to either male or female.

Statistical Information

P-Value

0.0035 for phosphatidylcholine, 0.0137 for phosphatidylethanolamine, 0.000245 for ADP-ribosyl-L-arginine, 0.008 for cyanidin 5-O-beta-D-glucoside, 0.0092 for citric acid, 0.0051 for L-aspartic acid.

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3389/fphar.2024.1470142

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication